Won‐Jea Cho

2.6k total citations
76 papers, 2.3k citations indexed

About

Won‐Jea Cho is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Won‐Jea Cho has authored 76 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Organic Chemistry, 40 papers in Molecular Biology and 15 papers in Toxicology. Recurrent topics in Won‐Jea Cho's work include Cancer therapeutics and mechanisms (18 papers), Synthesis and biological activity (17 papers) and Bioactive Compounds and Antitumor Agents (15 papers). Won‐Jea Cho is often cited by papers focused on Cancer therapeutics and mechanisms (18 papers), Synthesis and biological activity (17 papers) and Bioactive Compounds and Antitumor Agents (15 papers). Won‐Jea Cho collaborates with scholars based in South Korea, China and Japan. Won‐Jea Cho's co-authors include Daulat Bikram Khadka, Yifeng Jin, Hue Thi My Van, Suhui Yang, Sanghee Kim, Joohun Ha, Eung-Seok Lee, Chul‐Ho Lee, Balachandar Nedumaran and Won Gu Jang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Diabetes.

In The Last Decade

Won‐Jea Cho

75 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Won‐Jea Cho South Korea 24 1.1k 956 241 237 226 76 2.3k
Sheng-Chu Kuo Taiwan 34 1.6k 1.4× 1.5k 1.6× 323 1.3× 337 1.4× 348 1.5× 101 3.3k
Vivek Asati India 23 1.1k 0.9× 1.4k 1.5× 110 0.5× 337 1.4× 275 1.2× 96 2.7k
Prasad Dandawate United States 29 1.2k 1.0× 653 0.7× 423 1.8× 551 2.3× 188 0.8× 67 2.6k
Hongtao Xu China 33 1.7k 1.5× 1.2k 1.2× 235 1.0× 230 1.0× 168 0.7× 115 3.2k
Jing‐Ru Weng Taiwan 30 1.8k 1.6× 677 0.7× 235 1.0× 269 1.1× 372 1.6× 107 3.0k
Michel Koch France 28 1.3k 1.2× 1.3k 1.3× 230 1.0× 183 0.8× 414 1.8× 151 2.9k
Daniel D. Lantvit United States 31 1.4k 1.2× 315 0.3× 153 0.6× 339 1.4× 309 1.4× 88 2.8k
Shulin Yang China 21 929 0.8× 558 0.6× 112 0.5× 205 0.9× 306 1.4× 43 2.0k
Suresh Thareja India 22 839 0.7× 759 0.8× 140 0.6× 227 1.0× 143 0.6× 100 2.0k
Xiaoan Wen China 27 1.2k 1.0× 997 1.0× 92 0.4× 223 0.9× 64 0.3× 94 2.3k

Countries citing papers authored by Won‐Jea Cho

Since Specialization
Citations

This map shows the geographic impact of Won‐Jea Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won‐Jea Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won‐Jea Cho more than expected).

Fields of papers citing papers by Won‐Jea Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won‐Jea Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won‐Jea Cho. The network helps show where Won‐Jea Cho may publish in the future.

Co-authorship network of co-authors of Won‐Jea Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Won‐Jea Cho. A scholar is included among the top collaborators of Won‐Jea Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won‐Jea Cho. Won‐Jea Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Ying, Qianqian Wu, Zhichao Chen, et al.. (2024). Discovery of novel osthole derivatives exerting anti-inflammatory effect on DSS-induced ulcerative colitis and LPS-induced acute lung injury in mice. European Journal of Medicinal Chemistry. 268. 116252–116252. 5 indexed citations
2.
Chen, Pan, Ying Zhou, Xiaobo Li, et al.. (2023). Design, Synthesis, and Bioevaluation of Novel MyD88 Inhibitor c17 against Acute Lung Injury Derived from the Virtual Screen. Journal of Medicinal Chemistry. 66(10). 6938–6958. 13 indexed citations
3.
Chen, Pan, Jun Yang, Ying Zhou, et al.. (2023). Design, synthesis, and bioactivity evaluation of novel amide/sulfonamide derivatives as potential anti-inflammatory agents against acute lung injury and ulcerative colitis. European Journal of Medicinal Chemistry. 259. 115706–115706. 11 indexed citations
4.
Lee, Myoung Kyu, et al.. (2022). Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents. Drug Discovery Today. 27(7). 1895–1912. 17 indexed citations
5.
Han, Yong‐Hyun, Kyong‐Oh Shin, Daulat Bikram Khadka, et al.. (2019). A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. Journal of Clinical Investigation. 129(4). 1684–1698. 115 indexed citations
6.
Park, Sun Hong, Jae‐Kyung Jung, Won‐Jea Cho, et al.. (2017). Caffeic Acid Cyclohexylamide Rescues Lethal Inflammation in Septic Mice through Inhibition of IκB Kinase in Innate Immune Process. Scientific Reports. 7(1). 41180–41180. 9 indexed citations
7.
Park, Sun Hong, Sang‐Hun Jung, Byeongwoo Ahn, et al.. (2017). Piperidylmethyloxychalcone improves immune-mediated acute liver failure via inhibiting TAK1 activity. Experimental & Molecular Medicine. 49(11). e392–e392. 4 indexed citations
9.
Jin, Yifeng, Younho Han, Daulat Bikram Khadka, et al.. (2016). Discovery of Isoquinolinoquinazolinones as a Novel Class of Potent PPARγ Antagonists with Anti-adipogenic Effects. Scientific Reports. 6(1). 34661–34661. 11 indexed citations
10.
Lee, Sun‐Mi, Hyo‐Jeong Lee, Ji Won Kim, et al.. (2016). The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3. Bioorganic & Medicinal Chemistry. 24(21). 5036–5046. 18 indexed citations
11.
Zhao, Chao, Daulat Bikram Khadka, & Won‐Jea Cho. (2016). Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity. Current Medicinal Chemistry. 23(13). 1331–1355. 9 indexed citations
12.
Jin, Yifeng, Daulat Bikram Khadka, & Won‐Jea Cho. (2015). Pharmacological effects of berberine and its derivatives: a patent update. Expert Opinion on Therapeutic Patents. 26(2). 229–243. 137 indexed citations
13.
Chung, Kyung‐Sook, Hye‐Eun Choi, Ji‐Sun Shin, et al.. (2013). 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells. Carcinogenesis. 34(8). 1852–1860. 9 indexed citations
14.
Chung, Kyung‐Sook, et al.. (2010). CWJ-081, a novel 3-arylisoquinoline derivative, induces apoptosis in human leukemia HL-60 cells partially involves reactive oxygen species through c-Jun NH2-terminal kinase pathway. Bioorganic & Medicinal Chemistry Letters. 20(22). 6447–6451. 14 indexed citations
15.
Yang, Suhui, Daulat Bikram Khadka, Kwang Youl Lee, et al.. (2010). Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors. Bioorganic & Medicinal Chemistry. 19(2). 968–977. 41 indexed citations
16.
Karki, Radha, Mi Jeong Kang, Tae Cheon Jeong, et al.. (2010). Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines. Bioorganic & Medicinal Chemistry. 18(9). 3066–3077. 82 indexed citations
17.
Zhao, Longxuan, Arjun Basnet, Eun‐Kyung Kim, et al.. (2004). Synthesis, topoisomerase I inhibition and structure–activity relationship study of 2,4,6-trisubstituted pyridine derivatives. Bioorganic & Medicinal Chemistry Letters. 14(5). 1333–1337. 87 indexed citations
18.
Cho, Won‐Jea, et al.. (2000). A Convenient Synthesis of 5-Methylbenzo(c)phenanthridin-6(5H)-one. Bulletin of the Korean Chemical Society. 21(10). 980–984. 3 indexed citations
19.
Cho, Won‐Jea, et al.. (1998). Synthesis of antineoplaston A10 analogs as potential antitumor agents. Archives of Pharmacal Research. 21(2). 157–163. 3 indexed citations
20.
Cho, Won‐Jea, et al.. (1997). Synthesis and antitumor activity of 3-arylisoquinoline derivatives. Archives of Pharmacal Research. 20(3). 264–268. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026